AVTX

Avalo Therapeutics, Inc. Common Stock · polygon

$16.12-$1.06 (-6.17%)

Loading chart data...

Today · since the open

Day range

16.0218.14

52-week range

9.5424.27

Open

$17.42

Prev close

$17.18

$864.52M

Mkt cap

2.53M

Volume

P/E ratio

Div yield

AVTX on Stonx

Live community data

Players hold it

Today's fills are buys

Most held in your games

Avg holder return

Community trading data for AVTX is loading…

About Avalo Therapeutics, Inc. Common Stock

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

www.avalotx.com

Why it's moving

No related stocks found

AVTX

AVTX on Stonx

About Avalo Therapeutics, Inc. Common Stock

Why it's moving

Related